We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAZR
3751
PUT
DELISTED
Luminar Technologies
LAZR
$660K ﹤0.01%
+2,820
New +$746K
WTRG icon
3752
Essential Utilities
WTRG
$11.6B
$660K ﹤0.01%
+14,326
New +$694K
EZPW icon
3753
Ezcorp Inc
EZPW
$2.11B
$659K ﹤0.01%
87,098
-157,193
-64% -$1.01M
XPRO icon
3754
Expro Ltd
XPRO
$1.96B
$659K ﹤0.01%
37,364
-68,182
-65% -$1.16M
OVV icon
3755
PUT
Ovintiv
OVV
$17.9B
$658K ﹤0.01%
20,000
KNTE
3756
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$655K ﹤0.01%
28,468
+7,711
+37% +$168K
LAC
3757
DELISTED
Lithium Americas Corp. Common Shares
LAC
$654K ﹤0.01%
+29,289
New +$515K
GPRE icon
3758
CALL
Green Plains
GPRE
$1.04B
$653K ﹤0.01%
20,000
SRCL
3759
DELISTED
Stericycle Inc
SRCL
$653K ﹤0.01%
9,603
-463
-5% -$32K
AISP
3760
Airship AI Holdings
AISP
$73.7M
$650K ﹤0.01%
+66,987
New +$648K
ATVI
3761
CALL
DELISTED
Activision Blizzard
ATVI
$650K ﹤0.01%
8,400
+1,100
+15% +$91.9K
HIMX
3762
PUT
Himax Technologies
HIMX
$2.41B
$649K ﹤0.01%
+60,800
New +$780K
KEY icon
3763
PUT
KeyCorp
KEY
$23.6B
$649K ﹤0.01%
30,000
PBF icon
3764
CALL
PBF Energy
PBF
$8.31B
$649K ﹤0.01%
50,000
-500,000
-91% -$5.19M
PENG
3765
Penguin Solutions Inc
PENG
$2.62B
$649K ﹤0.01%
29,186
-13,014
-31% -$311K
ENJY
3766
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$648K ﹤0.01%
64,835
INBK icon
3767
First Internet Bancorp
INBK
$246M
$647K ﹤0.01%
20,757
-62
-0.3% -$1.88K
TGTX icon
3768
TG Therapeutics
TGTX
$8.48B
$647K ﹤0.01%
19,438
-138,142
-88% -$4.27M
VSEC icon
3769
VSE Corp
VSEC
$6.29B
$647K ﹤0.01%
13,441
+1,464
+12% +$71.2K
WTS icon
3770
Watts Water Technologies
WTS
$12.5B
$645K ﹤0.01%
3,839
-576
-13% -$92.3K
OTRA
3771
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
$645K ﹤0.01%
63,887
+12,146
+23% +$122K
AQN icon
3772
Algonquin Power & Utilities
AQN
$4.4B
$644K ﹤0.01%
43,900
-113,258
-72% -$1.75M
DLB icon
3773
Dolby
DLB
$6.16B
$644K ﹤0.01%
+7,321
New +$710K
SBRA icon
3774
Sabra Healthcare REIT
SBRA
$5.37B
$644K ﹤0.01%
43,714
-521,589
-92% -$8.81M
AVB
3775
PUT
DELISTED
AvalonBay Communities
AVB
$643K ﹤0.01%
+2,900
New +$651K

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.